BioCentury | Apr 10, 2020
Product Development

April 9 Quick Takes: BMS tops off CAR T patent win; plus approval for Braftovi plus Erbitux, Merck, BMS, Liquidia, Circassia-AZ, Bridge

...commercialization deal with AstraZeneca plc (LSE:AZN; NYSE:AZN) for Tudorza Pressair aclidinium bromide and Duaklir Pressair aclidinium bromide/formoterol fumarate...
BioCentury | Jun 29, 2019
Finance

Biotech backs down in 2Q19

...tumors Circassia Pharmaceuticals plc (LSE:CIR) Licensed U.S. righs from AstraZeneca plc FDA approves Duaklir Pressair aclidinium bromide/formoterol fumarate...
BioCentury | Apr 5, 2019
Company News

FDA approves Circassia's COPD treatment, AZ gets $20M milestone

...Circassia said FDA approved Duaklir Pressair aclidinium bromide/formoterol fumarate to treat chronic obstructive pulmonary disease. The agency also...
...Writer Bretaris Genuair, Eklira Genuair, Tudorza Genuair, Tudorza Pressair, aclidinium bromide (tudorza, LAS34273) Brimica Genuair, Duaklir Genuair, aclidinium bromide/formoterol fumarate (KRP-AB1102F, LAS40464) AstraZeneca...
BioCentury | Jan 17, 2019
Regulation

Products on shutdown standby

...Resubmission AstraZeneca plc (LSE:AZN; NYSE:AZN) Circassia Pharmaceuticals plc (LSE:CIR) has U.S. marketing rights Duaklir Pressair aclidinium bromide/formoterol fumarate...
BioCentury | Aug 17, 2018
Clinical News

FDA accepts applications for Circassia COPD products Duaklir, Tudorza

...Circassia Pharmaceuticals plc (LSE:CIR) said FDA accepted for review an NDA for Duaklir Pressair aclidinium bromide/formoterol fumarate to...
...Circassia Pharmaceuticals plc (LSE:CIR), Oxford, U.K. AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Product: Duaklir Pressair aclidinium bromide/formoterol fumarate...
...Leon Bretaris Genuair, Eklira Genuair, Tudorza Genuair, Tudorza Pressair, aclidinium bromide (tudorza, LAS34273) Brimica Genuair, Duaklir Genuair, aclidinium bromide/formoterol fumarate (KRP-AB1102F, LAS40464) AstraZeneca...
BioCentury | Dec 1, 2017
Clinical News

Duaklir Genuair meets in Phase III to treat COPD

...1,595 patients with chronic obstructive pulmonary disease (COPD) showing that Duaklir Genuair aclidinium bromide/formoterol (Brimica, KRP-AB1102F, LAS40464...
...forced expiratory volume in 1 second (FEV1) from baseline vs. aclidinium bromide or formoterol alone. Duaklir Genuair...
...plc (LSE:CIR), Oxford, U.K. AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Product: Duaklir Genuair aclidinium bromide/formoterol fumarate (Brimica, KRP-AB1102F, LAS40464...
BioCentury | Apr 28, 2017
Finance

A different animal?

...to the COPD therapy. The deal also gives Circassia full U.S. rights to Duaklir Pressair aclidinium bromide/formoterol fumarate...
BioCentury | Apr 21, 2017
Clinical News

HDM-SPIRE: Ph IIb data

Top-line data from a double-blind, international Phase IIb trial in 714 house dust mite allergic patients with moderate or severe allergy symptoms showed that 12 and 20 nmol HDM-SPIRE every 4 weeks for 12 weeks...
BioCentury | Apr 18, 2017
Clinical News

Circassia abandoning allergy field after Phase IIb miss

...beta agonist (LABA) formoterol. Circassia lost 1.75p to 101.25p on Tuesday. Jaime De Leon aclidinium bromide Aclidinium bromide/formoterol fumarate Bretaris Genuair Brimica Genuair Duaklir Genuair Eklira Genuair HDM-SPIRE KRP-AB1102F LAS34273 LAS40464 ToleroMune...
BioCentury | Mar 23, 2017
Company News

AZ, Circassia deal

...NYSE:AZN), London, U.K. Circassia Pharmaceuticals plc (LSE:CIR), Oxford, U.K. Business: Pulmonary Jaime De Leon aclidinium bromide Aclidinium bromide/formoterol fumarate benralizumab Bretaris Genuair Brimica Genuair Duaklir Genuair Eklira Genuair KHK4563 KRP-AB1102F LAS40464 MEDI-563 Tudorza Tudorza...
Items per page:
1 - 10 of 32